Walleye Capital’s Bicycle Therapeutics BCYC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.99K Buy
1,900
+1,700
+850% +$6.88K ﹤0.01% 5771
2026
Q2
$848 Buy
+200
New +$917 ﹤0.01% 4610
2025
Q3
– Sell
-1,500
Closed -$10.4K – 4501
2025
Q2
$10.4K Buy
+1,500
New +$11.9K ﹤0.01% 4305

Other funds holding BCYC

Walleye Capital's BCYC Position: Q3 2026 in Review

Walleye Capital sold out of Bicycle Therapeutics (BCYC) in Q3 2026, closing a stake of 13,000 shares — an estimated $52.6K sold.

Walleye Capital first reported a position in BCYC in Q4 2023 and held it in 4 quarters. The position peaked at $2.71M in Q4 2023. 90 funds tracked by Wall St. Rank hold BCYC as of Q3 2026.

  • Walleye Capital reported no remaining Bicycle Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Walleye Capital sold 13,000 Bicycle Therapeutics shares in Q3 2026, an estimated $52.6K.
  • Walleye Capital first reported a position in Bicycle Therapeutics in Q4 2023 and held it in 4 quarters.
  • Walleye Capital's Bicycle Therapeutics position peaked at $2.71M in Q4 2023.
  • 90 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.